AzTrials
AzTrials

Social AnxietyPRIVATENCT06465589

Variations of Anonymity, Transparency, and Efficacy in Digital Health Applications

A study testing JOURNeY anonymous and JOURNeY standard in people with Social Anxiety, run by University of Bern at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Social Anxiety Disorder (SAD) is one of the most widespread mental illnesses and it has previously been shown that online therapy and online self-help tools such as the one investigated in this study can be successful in reducing not only symptoms of SAD but also symptoms of depression and increase the quality of life… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Social Anxiety
What is being tested?
JOURNeY anonymous and JOURNeY standard
Could I receive a placebo?
No, everyone receives an active treatment
How many people
452 participants
Where
1 siteSwitzerland
Study dates
3 Sep 2024to 2 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Written informed consent
  • Be 18 years or older,
  • Have access to the internet
  • Have access to a smartphone, computer or tablet
  • Score 22 points or higher on the Social Phobia Scale or 33 points or higher on the Social Interaction Anxiety Scale (SPS \& SIAS)

Who cannot join

  • Score 2 points or higher on the suicide item of the PHQ-9
  • Have previously been diagnosed with psychotic symptoms or bipolar disorder

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • University Bern, Clinical Psychology and Psychotherapy Department

    Bern, 3012

Other trials in Switzerland

About this study

Official title: PRIVATE - Preference Research: Investigating Variations of Anonymity, Transparency, and Efficacy in Digital Health Applications

Social Anxiety Disorder (SAD) is one of the most widespread mental illnesses and it has previously been shown that online therapy and online self-help tools such as the one investigated in this study can be successful in reducing not only symptoms of SAD but also symptoms of depression and increase the quality of life of participants. A substantial concern with digital health intervention tools is data security and privacy as many such tools have been found to be unsafe and easy targets for hacker attacks, potentially endangering personal (health) data of the users.

For this research project, an internet-based program targeting social anxiety has been developed that can be used completely anonymously (i.e., without collecting an email address or other information that can or could potentially identify users). This new anonymized version will be compared in a partially randomized patient preference trial with an already well-evaluated version in which, as is common in other digital health applications, personal data such as the email address or other information from the users is used, for example, for login.

Read more

Study objectives:

  1. To investigate the efficacy of a completely anonymous version of the program "JOURNeY" based on cognitive behavioral therapy (CBT) and compare it to an already evidence-based non-anonymous version of the program regarding primary social anxiety symptoms, and secondary outcomes such as depressive symptoms, quality of life, usability, adherence to the program, internalized stigma, attitudes on help-seeking, and personality functioning.
  2. To investigate patients' preferences and the influence of patients' preferences on outcome.
  3. To explore how patient characteristics are associated with participants' preferences.
Read the detailed description

Social Anxiety Disorder (SAD) is one of the most widespread mental illnesses and it has previously been shown that online therapy and online self-help tools such as the one investigated in this study can be successful in reducing not only symptoms of SAD but also symptoms of depression and increase the quality of life of participants. A substantial concern with digital health intervention tools is data security and privacy as many such tools have been found to be unsafe and easy targets for hacker attacks, potentially endangering personal (health) data of the users.

For this research project, an internet-based program targeting social anxiety has been developed that can be used completely anonymously (i.e., without collecting an email address or other information that can or could potentially identify users). It is originally based on the well-established cognitive-behavioral treatment of social anxiety by Clark and Wells from 1995. This new anonymized version will be compared in a partially randomized patient preference trial with an already well-evaluated version in which, as is common in other digital health applications, personal data such as the email address or other information from the users is used, for example, for login. The fully anonymized version has some disadvantages regarding usability and possibly also effectiveness, as no usage history can be stored, users cannot pick up where they left off during a new login, and instead of entering texts in diaries, for example, about anxiety-related thoughts within the program, they need to download a PDF, etc. On the other hand, the anonymized version has advantages regarding the low threshold for use and privacy. People who could benefit from such internet-based programs might be more likely to use them, as there are no data protection risks associated with their use, and a fully anonymized version could immediately be used even without entering an email address. Thus, the reach and impact of evidence-based digital tools for mental problems and disorders such as social anxiety (disorder) could be increased with an anonymous version. However, there are no studies on the effectiveness of digital tools which can be used anonymously and there is no knowledge about the preferences of users (e.g., is it important for users to be able to use an anonymous version, or do they prefer the non-anonymized version with a few practical advantages?).

Study objectives:

  1. To investigate the efficacy of a completely anonymous version of the CBT-based program "JOURNeY" and compare it to an already evidence-based non-anonymous version of the program regarding primary social anxiety symptoms, and secondary outcomes such as depressive symptoms, quality of life, usability, adherence to the program, internalized stigma, attitudes on help-seeking, and personality functioning.
  2. To investigate patients' preferences and the influence of patients' preferences on outcome.
  3. To explore how patient characteristics are associated with participants' preferences.

This study is part of a larger trial conducted with two departments at the University of Bern. One part assesses clinical research questions and the other part is concerned with psychology of digitalization which researches user behavior and concerns regarding privacy in digital health applications.

The study is a single-center partially randomized patient preference trial and for the clinical part, there are two experimental factors (program versions, i.e. anonymous and standard) each evaluated at two levels (randomized vs. preferred).

Recruitment: Participants will be recruited using reports in newspapers, through internet forums, social media (e.g., Facebook), and via a website (https://www.online-therapy.ch/) in German-speaking countries.

Sampling: After checking the inclusion criteria, participants will be randomized with equal probability to one of the two conditions; randomization vs. preference. In the second stage, if a participant is randomized to the choice arm, the participant can choose the preferred treatment; if a participant is randomized to the random arm, the participant is randomized to a program version (anonymous vs. standard) arm. This design is used to estimate the treatment, selection, and preference effect. The random allocation will be unknown to the investigators. In order to keep the sample sizes of the 16 conditions similar, the allocation list will be made using randomly permuted blocks.

A total of 452 participants who exceed pre-defined cut-off scores on social anxiety measures will be recruited for this study.

Assessment procedures: The primary outcome measure is change in symptoms of SAD at post-treatment, i.e., after 8 weeks. Secondary outcomes include sustaining change at follow up (6 months after baseline), changes in depressive symptoms, changes in quality of life, changes in internalized stigma and attitudes towards help-seeking, changes in levels of personality functioning, and negative effects. Furthermore, an exploratory preference analysis will be conducted to gain insights into digital health application users' preferences and potential preference effect.

Treatment: The internet-based self-help program ("JOURNeY") is based on the well-established cognitive-behavioral treatment of social anxiety by Clark and Wells from 1995 and has been proven efficacious in previous studies. The standard version of JOURNeY is accessed through a secure website, with each participant having a password-protected account. It consists of the following four treatment components: (1) psychoeducation (knowledge about SAD and its treatment); (2) cognitive restructuring (challenging dysfunctional social cognitions); (3) attention training (decrease of self-focused attention); and (4) exposure (decrease of avoidance of feared situations and safety behaviors). The anonymous version has the same content but does not require an account and does not collect any personal data of participants.

Data analysis: Primary analyses will be conducted on the Intention-To-Treat (ITT) sample (i.e., all assigned participants) using linear mixed models with repeated measures. In addition, a completers analysis will be carried out, also with linear mixed models with repeated measures.

For the preference analysis, a more exploratory approach will be used. For binary outcome data (e.g. program preference), regression analysis will be conducted. For other data, tests such as t-test, chi-squared tests or other appropriate tests will be used.

Reporting will follow CONSORT E-Health standards.

Conditions
Social Anxiety
Being tested
JOURNeY anonymous, JOURNeY standard
Keywords
Social Anxiety, Mental Disorders, Internet Intervention, Self Help, Preference
Medical subject headings
Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • JOURNeY anonymousOther

    The anonymously usable version of the self-help program JOURNeY which does not require a login and does not collect personal data.

    Includes 4 main components:

    1. psychoeducation where participants learn about SAD and the treatment,
    2. cognitive restructuring where participants challenge dysfunctional social cognitions,
    3. attention training where participants learn to decrease self-focused attention, and
    4. exposure where participants seek out and endure fear-inducing situations.

    Additionally, there is a first module which discusses motivation and a conclusion module which encourages participants to keep practicing and using techniques they learned in the program in their daily life.

  • JOURNeY standardOther

    The standard version of the self-help program JOURNeY which requires a login and collects personal data.

    Includes 4 main components:

    1. psychoeducation where participants learn about SAD and the treatment,
    2. cognitive restructuring where participants challenge dysfunctional social cognitions,
    3. attention training where participants learn to decrease self-focused attention, and
    4. exposure where participants seek out and endure fear-inducing situations.

    Additionally, there is a first module which discusses motivation and a conclusion module which encourages participants to keep practicing and using techniques they learned in the program in their daily life.

Study groups in NCT06465589
Study groupRoleWhat they receive
Randomized AnonymousExperimentalAfter participants are randomized to the randomization arm, they will once again be randomized to the program versions. Participants in this arm will use the anonymous program.
Receives: Other: JOURNeY anonymous
Randomized StandardActive comparatorAfter participants are randomized to the randomization arm, they will once again be randomized to the program versions. Participants in this arm will use the standard program.
Receives: Other: JOURNeY standard
Preferred AnonymousOtherAfter participants are randomized to the preference arm, they will be given access to the program version they indicate a preference for after having read two descriptive texts about both versions. Participants in this arm will use the anonymous program.
Receives: Other: JOURNeY anonymous
Preferred StandardOtherAfter participants are randomized to the preference arm, they will be given access to the program version they indicate a preference for after having read two descriptive texts about both versions. Participants in this arm will use the standard program.
Receives: Other: JOURNeY standard

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Social Anxiety Symptoms

    Change from baseline in the composite score of two self-report social anxiety questionnaires measuring various symptoms from time pre to time post (Social Phobia Scale \& Social Interaction Anxiety Scale; SPS \& SIAS). The scales contain a total of 40 items resulting in scores of 0 to 160 with higher scores indicating more severe social anxiety symptoms. The composite score will be the averaged z-score of both questionnaires.

    Measured: at baseline, 8 Weeks

Secondary outcomes (6)
  1. Social Anxiety Symptoms

    Change in the composite score and individual scores of two self-report social anxiety questionnaires measuring various symptoms from time pre to time post and follow-up (Social Phobia Scale \& Social Interaction Anxiety Scale; SPS \& SIAS). The scales contain a total of 40 items resulting in scores of 0 to 160 with higher scores indicating more severe social anxiety symptoms. The composite score will be the averaged z-score of both questionnaires.

    Measured: at baseline, at 8 weeks, at 24 weeks

  2. Depressive Symptoms

    Changes in depressive symptoms measured with one self-report questionnaire from time pre to time post and follow-up (Patient Health Questionnaire; PHQ-9). This nine item questionnaire results in scores ranging from 0 to 27 with higher scores indicating more severe depressive symptoms.

    Measured: at baseline, at 8 weeks, at 24 weeks

  3. Quality of Life QoL

    Changes in quality of Life measured with one self-report questionnaire from time pre to time post and follow-up (Short-Form Health Survey SF-12; SF-12). The twelve items measure quality of life on the two subscales physical and mental aspects. Scores range from 0 to 100 with higher scores indicating higher quality of life.

    Measured: at baseline, at 8 weeks, at 24 weeks

  4. Internalized Stigma

    Changes in internalized stigma of mental illnesses measured with one self-report questionnaire from time pre to time post and follow-up (Internalized Stigma of Mental Illness Scale; ISMI). It has 29 items and measures stigma on the five subscales alienation, stereotype endorsement, discrimination experience, social withdrawal, and stigma resistance. Overall scores range from 29 to 116 with higher scores indicating higher internalized stigma.

    Measured: at baseline, at 8 weeks, at 24 weeks

  5. Attitudes Towards Help-Seeking

    Changes of attitudes towards seeking mental health services measured with one self-report questionnaire from time pre to time post and follow-up (Inventory of Attitudes Towards Seeking Mental Health Services; IASMHS). The questionnaire has 24 items with the three subscales psychological openness, help-seeking propensity, and indifference to stigma. Scores range from 0 to 20 for each subscale. For psychological openness and help seeking propensity, higher scores indicate more positive attitudes towards help-seeking. For stigma indifference, higher scores indicate less concern about stigma associated with help-seeking.

    Measured: at baseline, at 8 weeks, at 24 weeks

  6. Personality Functioning

    Changes in personality functioning measured with one self-report questionnaire from time pre to time post and follow-up (Level of Personality Functioning Scale-Brief Form 2.0; LPFS-BF). This 12-item questionnaire measures personality functioning with the two domains self (subscales: identity and self-direction) and interpersonal (subscales: empathy and intimacy) functioning. Overall scores range from 12 to 48 with higher scores indicating more severe impairment in personality functioning.

    Measured: at baseline, at 8 weeks, at 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jun 2024
  2. Study start3 Sep 2024
  3. Primary completion2 Mar 2026
  4. Study completion2 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The study is a single-center partially randomized patient preference trial with four conditions (program version: standard vs. anonymous and allocation: randomized vs. preferred)
Masking
Single blind
Who is masked
Investigator
Enrolment
452 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06465589
Sponsor's protocol ID
2024-00842
Other IDs
10002000, SNCTP000005924
Acronym
PRIVATE
Status last verified
Apr 2026
First submitted
13 Jun 2024
Last updated
20 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Clark, D. M., & Wells, A. (1995). A cognitive model of social phobia. In R. G. Heimberg, M. R. Liebowitz, D. Hope, & F. Schneider (Eds.), Social Phobia: Diagnosis, Assessment, and Treatment (pp. 69-93). Guilford Press.

  • Schulz A, Stolz T, Vincent A, Krieger T, Andersson G, Berger T. A sorrow shared is a sorrow halved? A three-arm randomized controlled trial comparing internet-based clinician-guided individual versus group treatment for social anxiety disorder. Behav Res Ther. 2016 Sep;84:14-26. doi: 10.1016/j.brat.2016.07.001. Epub 2016 Jul 7.

    PubMed 27423374
  • Sibitz I, Friedrich ME, Unger A, Bachmann A, Benesch T, Amering M. [Internalized Stigma of Schizophrenia: Validation of the German Version of the Internalized Stigma of Mental Illness-Scale (ISMI)]. Psychiatr Prax. 2013 Mar;40(2):83-91. doi: 10.1055/s-0032-1332878. Epub 2013 Jan 25. German.

    PubMed 23354628
  • Stolz T, Schulz A, Krieger T, Vincent A, Urech A, Moser C, Westermann S, Berger T. A mobile app for social anxiety disorder: A three-arm randomized controlled trial comparing mobile and PC-based guided self-help interventions. J Consult Clin Psychol. 2018 Jun;86(6):493-504. doi: 10.1037/ccp0000301.

    PubMed 29781648
  • Gräfe, K., Zipfel, S., Herzog, W., & Löwe, B. (2004). Screening psychischer Störungen mit dem "Gesundheitsfragebogen für Patienten (PHQ-D)". Diagnostica, 50(4), 171-181. https://doi.org/10.1026/0012-1924.50.4.171

  • Berger T, Caspar F, Richardson R, Kneubuhler B, Sutter D, Andersson G. Internet-based treatment of social phobia: a randomized controlled trial comparing unguided with two types of guided self-help. Behav Res Ther. 2011 Mar;49(3):158-69. doi: 10.1016/j.brat.2010.12.007. Epub 2011 Jan 1.

    PubMed 21255767
  • Kessler EM, Agines S, Bowen CE. Attitudes towards seeking mental health services among older adults: personal and contextual correlates. Aging Ment Health. 2015;19(2):182-91. doi: 10.1080/13607863.2014.920300. Epub 2014 Jun 5.

    PubMed 24898327
  • Wolfangel, E. (2023, May 9). Datenschutz: Wenn Hacker mit Gesundheits-Apps besonders leichtes Spiel haben. ZEIT ONLINE. https://www.zeit.de/digital/datenschutz/2023-05/gesundheitsapp-datenschutz-depression-edupression-sicherheitsluecke/komplettansicht

  • Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998 Nov;51(11):1171-8. doi: 10.1016/s0895-4356(98)00109-7.

    PubMed 9817135
  • Batterham P, Gulliver A, Sunderland M, Farrer L, Kay-Lambkin F, Trias A, Calear A. Factors Influencing Community Participation in Internet Interventions Compared With Research Trials: Observational Study in a Nationally Representative Adult Cohort. J Med Internet Res. 2023 Feb 2;25:e41663. doi: 10.2196/41663.

    PubMed 36729613
  • Spitzer C, Muller S, Kerber A, Hutsebaut J, Brahler E, Zimmermann J. [The German Version of the Level of Personality Functioning Scale-Brief Form 2.0 (LPFS-BF): Latent Structure, Convergent Validity and Norm Values in the General Population]. Psychother Psychosom Med Psychol. 2021 Jul;71(7):284-293. doi: 10.1055/a-1343-2396. Epub 2021 Mar 10. German.

    PubMed 33694153
  • Stein DJ, Lim CCW, Roest AM, de Jonge P, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Benjet C, Bromet EJ, Bruffaerts R, de Girolamo G, Florescu S, Gureje O, Haro JM, Harris MG, He Y, Hinkov H, Horiguchi I, Hu C, Karam A, Karam EG, Lee S, Lepine JP, Navarro-Mateu F, Pennell BE, Piazza M, Posada-Villa J, Ten Have M, Torres Y, Viana MC, Wojtyniak B, Xavier M, Kessler RC, Scott KM; WHO World Mental Health Survey Collaborators. The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. BMC Med. 2017 Jul 31;15(1):143. doi: 10.1186/s12916-017-0889-2.

    PubMed 28756776
  • Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther. 1998 Apr;36(4):455-70. doi: 10.1016/s0005-7967(97)10031-6.

    PubMed 9670605
  • Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999 Nov 10;282(18):1737-44. doi: 10.1001/jama.282.18.1737.

    PubMed 10568646
  • Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996 Mar;34(3):220-33. doi: 10.1097/00005650-199603000-00003.

    PubMed 8628042

Questions about this trial

What is this clinical trial studying?

A study testing JOURNeY anonymous and JOURNeY standard in people with Social Anxiety, run by University of Bern at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Social Anxiety Symptoms (time frame: at baseline, 8 Weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06465589, which also lists 20 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in